Somewhat Positive Media Coverage Somewhat Likely to Impact NCI (NCIT) Stock Price

Headlines about NCI (NASDAQ:NCIT) have trended somewhat positive this week, according to AlphaOne. The research firm, a subsidiary of Accern, scores the sentiment of press coverage by reviewing more than 20 million blog and news sources in real time. AlphaOne ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. NCI earned a daily sentiment score of 0.15 on AlphaOne’s scale. AlphaOne also assigned media coverage about the information technology services provider an impact score of 60 out of 100, meaning that recent press coverage is somewhat likely to have an impact on the stock’s share price in the next several days.

NCI (NASDAQ:NCIT) traded up 0.79% during mid-day trading on Thursday, hitting $19.20. The company had a trading volume of 59,276 shares. The stock’s 50 day moving average price is $14.99 and its 200 day moving average price is $14.08. The firm has a market cap of $260.18 million, a P/E ratio of 42.95 and a beta of 1.02. NCI has a 52-week low of $10.98 and a 52-week high of $19.60.

NCI (NASDAQ:NCIT) last released its quarterly earnings data on Tuesday, May 9th. The information technology services provider reported $0.25 earnings per share for the quarter, topping the consensus estimate of $0.21 by $0.04. The business had revenue of $78.75 million during the quarter, compared to analyst estimates of $76.55 million. NCI had a return on equity of 12.10% and a net margin of 4.06%. On average, equities research analysts predict that NCI will post $1.01 EPS for the current fiscal year.

Several research analysts have weighed in on the company. Zacks Investment Research downgraded NCI from a “hold” rating to a “sell” rating in a research note on Saturday, April 8th. FBR & Co reiterated a “hold” rating and issued a $11.00 target price on shares of NCI in a research note on Tuesday, April 4th. Noble Financial reiterated a “buy” rating on shares of NCI in a research note on Friday, May 12th. Finally, Cowen and Company reiterated a “buy” rating and issued a $16.50 target price on shares of NCI in a research note on Monday, April 10th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. NCI currently has a consensus rating of “Buy” and a consensus price target of $13.75.

TRADEMARK VIOLATION WARNING: “Somewhat Positive Media Coverage Somewhat Likely to Impact NCI (NCIT) Stock Price” was originally reported by Mideast Time and is the sole property of of Mideast Time. If you are viewing this piece on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be read at https://www.mideasttime.com/somewhat-positive-media-coverage-somewhat-likely-to-impact-nci-ncit-stock-price/1725332.html.

About NCI

NCI, Inc is a provider of enterprise services and solutions to defense, intelligence, healthcare and civilian government agencies. The Company provides information technology (IT), and professional services and solutions by leveraging its core service offerings, which include cloud computing and IT infrastructure optimization; cybersecurity and information assurance; engineering and logistics support; enterprise information management and advanced analytics; health IT and medical support; IT service management; modeling, simulation, and training, and agile development and integration.

12 Month Chart for NASDAQ:NCIT

Receive News & Ratings for NCI Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCI Inc and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.